Cargando…
Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial
BACKGROUND: Fecal microbiota transplantation (FMT) via colonoscopy or enema has become a commonly used treatment of recurrent C. difficile infection (CDI). AIMS: To compare the safety and preliminary efficacy of orally administered lyophilized microbiota product compared with frozen product by enema...
Autores principales: | Jiang, Zhi-Dong, Jenq, Robert R., Ajami, Nadim J., Petrosino, Joseph F., Alexander, Ashley A., Ke, Shi, Iqbal, Tehseen, DuPont, Andrew W., Muldrew, Kenneth, Shi, Yushu, Peterson, Christine, Do, Kim-Anh, DuPont, Herbert L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214502/ https://www.ncbi.nlm.nih.gov/pubmed/30388112 http://dx.doi.org/10.1371/journal.pone.0205064 |
Ejemplares similares
-
Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017) -
Clostridium difficile Modulates the Gut Microbiota by Inducing the Production of Indole, an Interkingdom Signaling and Antimicrobial Molecule
por: Darkoh, Charles, et al.
Publicado: (2019) -
Accessory Gene Regulator-1 Locus Is Essential for Virulence and Pathogenesis of Clostridium difficile
por: Darkoh, Charles, et al.
Publicado: (2016) -
Erratum for Darkoh et al., “Accessory Gene Regulator-1 Locus Is Essential for Virulence and Pathogenesis of Clostridium difficile”
por: Darkoh, Charles, et al.
Publicado: (2017) -
Recent advances in the treatment of Clostridioides difficile infection: the ever-changing guidelines
por: Khurana, Shruti, et al.
Publicado: (2020)